Valneva Stock

Valneva Current Liabilities

The Current Liabilities of Valneva (VLA.PA) as of Aug 12, 2026 is 85.99 M EUR. In the previous year, Current Liabilities was 169.18 M EUR — a change of -49.17% (lower).

Current Liabilities

85.99 MEUR

YoY

-49.17%

Last updated:

Current Liabilities of Valneva is 2026 85.99 M EUR. Current Liabilities of Valneva was 2025 169.18 M EUR. It decreases by -49.17% lower compared to the previous year.
Access this data via the Eulerpool API

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Current Liabilities of Valneva is 85.99 M EUR in 2026.

Current Liabilities of Valneva changed from 169.18 M EUR to 85.99 M EUR, representing a -49.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Valneva since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Valneva historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Valneva

All Key Metrics — Valneva